Simultaneous stimulation with CD40/CpG ODN has been studied previously in CLL cells, observing enhanced immunogenicity[35] and distinctive proliferation in IGHV unmutated CLL cells correlating with the development of drug resistance[36]. The gene discussed is CD40; the disease is B-cell chronic lymphocytic leukemia.